{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:11:39Z","timestamp":1789161099378,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12072-018-9845-2","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T04:53:41Z","timestamp":1518584021000},"page":"143-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct acting antiviral therapy"],"prefix":"10.1007","volume":"12","author":[{"given":"Rasha","family":"Eletreby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdy","family":"ElSerafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosam","family":"Dabes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadry","family":"ElSaeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehia","family":"El-Shazly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahid","family":"Doss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"9845_CR1","doi-asserted-by":"crossref","unstructured":"Fallahi P, Ferrari SM, Ruffilli I, Elia G, Giuggioli D, Colaci M. Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up. Autoimmun Rev 2016 [In press].","DOI":"10.1016\/j.autrev.2016.03.012"},{"key":"9845_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.amjmed.2004.04.004","volume":"117","author":"Y Tomer","year":"2004","unstructured":"Tomer Y, Villanueva R. Hepatitis C and thyroid autoimmunity: is there a link? Am J Med 2004;117:60\u201361.","journal-title":"Am J Med"},{"key":"9845_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jaut.2009.11.008","volume":"34","author":"Y Tomer","year":"2010","unstructured":"Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun 2010;34:322\u20133226.","journal-title":"J Autoimmun"},{"key":"9845_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.006","author":"C Ferri","year":"2016","unstructured":"Ferri C, Ramos-Casals M, Zignego AL, On behalf of the ISG-EHCV coauthors, et al. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmun Rev 2016. https:\/\/doi.org\/10.1016\/j.autrev.2016.09.006 (Article in press).","journal-title":"Autoimmun Rev"},{"key":"9845_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2265.2007.03009.x","volume":"68","author":"G Indolfi","year":"2008","unstructured":"Indolfi G, Stagi S, Bartolini E, et al. Thyroid function and antithyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection. Clin Endocrinol 2008;68:117\u2013121.","journal-title":"Clin Endocrinol"},{"key":"9845_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrgastro.2009.168","volume":"6","author":"A Antonelli","year":"2009","unstructured":"Antonelli A, Ferri C, Fallahi P. Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy. Nat Rev Gastroenterol Hepatol 2009;6:633\u2013635.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9845_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1089\/105072503322238809","volume":"13","author":"MF Prummel","year":"2003","unstructured":"Prummel MF, Laurberg P. Interferon-\u03b1 and autoimmune thyroid disease. Thyroid 2003;13:547\u2013551.","journal-title":"Thyroid"},{"key":"9845_CR8","unstructured":"Rugge B, Balshem H, Sehgal R, Relevo R, Gorman P, Helfand M. Screening and treatment of subclinical hypothyroidism or hyperthyroidism. Comparative Effectiveness Review No. 24. Rockville, MD: Agency for Healthcare Research and Quality; 2011."},{"issue":"9","key":"9845_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.7326\/M15-0483","volume":"162","author":"ML LeFevre","year":"2015","unstructured":"LeFevre ML. Screening for thyroid dysfunction: U.S. preventive services task force recommendation statement. Ann Intern Med 2015;162(9):641\u2013650.","journal-title":"Ann Intern Med"},{"key":"9845_CR10","first-page":"467","volume-title":"The thyroid: a fundamental and clinical text","author":"MP Vanderpump","year":"2000","unstructured":"Vanderpump MP, Tunbridge WM. The epidemiology of thyroid diseases. In: Braverman LE, Utiger RD, editors. The thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 467\u2013473.","edition":"8"},{"issue":"1","key":"9845_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.amjmed.2004.01.023","volume":"117","author":"A Antonelli","year":"2004","unstructured":"Antonelli A, Ferri C, Pampana A, et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004;117(1):10\u201313.","journal-title":"Am J Med"},{"issue":"4","key":"9845_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1590\/S1413-86702011000400013","volume":"15","author":"LJ Andrade","year":"2011","unstructured":"Andrade LJ, Atta AM, Atta ML, Mangabeira CN, Parana R. Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy. Braz J Infect Dis 2011;15(4):377\u2013381.","journal-title":"Braz J Infect Dis"},{"key":"9845_CR13","volume-title":"A report card on nutrition, Number 4, May 2006","author":"Progress for Children","year":"2006","unstructured":"Progress for Children. A report card on nutrition, Number 4, May 2006. New York: UNICEF; 2006."},{"key":"9845_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1046\/j.1365-2265.1996.751768.x","volume":"44","author":"M Marazuela","year":"1996","unstructured":"Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) 1996;44:635\u2013642.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"9845_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1590\/S1413-86702011000500006","volume":"15","author":"MH Pavan","year":"2011","unstructured":"Pavan MH, Pavin EJ, Goncales FL, Wittmann DE. Virus C genotype predisposes to primary hypothyroidism during interferon-\u03b1 treatment for chronic hepatitis C. Braz J Infect Dis 2011;15(5):449\u2013456.","journal-title":"Braz J Infect Dis"},{"key":"9845_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1440-1746.1995.tb01106.x","volume":"10","author":"MJ Huang","year":"1995","unstructured":"Huang MJ, Liaw YF. Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol 1995;10:344\u2013350.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"9845_CR17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1665-2681(19)31891-5","volume":"7","author":"M Rodr\u00edguez-Torres","year":"2008","unstructured":"Rodr\u00edguez-Torres M, R\u00edos-Bedoya CF, Ortiz-Lasanta G, Marxuach-Cu\u00e9tara AM, Jim\u00e9nez-Rivera J. Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis. Ann Hepatol 2008;7(1):72\u201377.","journal-title":"Ann Hepatol"},{"issue":"6","key":"9845_CR18","first-page":"628","volume":"8","author":"KA El-Atrebi","year":"2016","unstructured":"El-Atrebi KA, El-Bassyouni HT, Zaki NA. Thyroid dysfunction as predictor of sustained virological response (SVR) During HCV treatment with PEGylated interferon and ribavirin. Int J Pharm Clin Res 2016;8(6):628\u2013631.","journal-title":"Int J Pharm Clin Res"},{"key":"9845_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12072-015-9684-3","volume":"10","author":"K Gill","year":"2016","unstructured":"Gill K, Ghazinian H, Manch R, Gish R. Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatol Int 2016;10:415\u2013423.","journal-title":"Hepatol Int"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-018-9845-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-018-9845-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-018-9845-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T23:06:18Z","timestamp":1570748778000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-018-9845-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["9845"],"URL":"https:\/\/doi.org\/10.1007\/s12072-018-9845-2","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,14]]},"assertion":[{"value":"12 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}